Beam Therapeutics
Trade Beam Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BEAM
Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201.
BEAM Key Statistics
Stock Snapshot
With a market cap of 2.94B, Beam Therapeutics(BEAM) trades at $29.14. The stock has a price-to-earnings ratio of -6.54.
During the trading session on 2026-01-29, Beam Therapeutics(BEAM) shares reached a daily high of $30.99 and a low of $28.37. At a current price of $29.14, the stock is +2.7% higher than the low and still -6.0% under the high.
Trading activity shows a volume of 2.11M, compared to an average daily volume of 2.07M.
The stock's 52-week range extends from a low of $13.53 to a high of $36.44.
The stock's 52-week range extends from a low of $13.53 to a high of $36.44.
Analyst ratings
89%
of 18 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Newly Listed
This list is generated by showing companies that recently went public.